Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fluralaner. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114394946A reveals a cost-effective Fluralaner synthesis route using 4-bromo-2-methylbenzoic acid, offering high purity and scalable manufacturing for global supply chains.
Patent CN115677605A reveals a mild 5-step route for S-Fluralaner. Achieve higher ee values and yields with cost-effective chiral thiourea catalysis for veterinary markets.
Novel one-pot synthesis of isoxazoline anthelmintic intermediates reduces steps and boosts yield for veterinary drug manufacturing supply chains.
Patent CN114957147A reveals a novel 3-step route for Fluralaner, offering high purity and reduced impurities for reliable agrochemical intermediate supply chains.
Novel patent CN113461653B offers a catalyst-free, ambient temperature route for Fluralaner intermediates, ensuring supply chain stability and reduced manufacturing costs for veterinary APIs.
Patent CN116640100A reveals solid-phase synthesis for Fluralaner. Enhances purity and yield for veterinary drug supply chains significantly.
Patent CN120230056A details a cost-effective fluralaner synthesis method enhancing purity and supply chain stability for global veterinary pharmaceutical manufacturers.
Patent CN120923436A reveals a low-cost synthesis route for Fluralaner intermediates. Enhance supply chain reliability and purity with scalable veterinary drug solutions.
Patent CN115304472A reveals a cost-effective 5-step route for Fluralaner intermediates. Discover how this non-cyanide process ensures high purity and supply stability.